Sinohealth Holdings Past Earnings Performance
Past criteria checks 5/6
Sinohealth Holdings has been growing earnings at an average annual rate of 12.9%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 16.8% per year. Sinohealth Holdings's return on equity is 14.4%, and it has net margins of 25.8%.
Key information
12.9%
Earnings growth rate
76.4%
EPS growth rate
Healthcare Services Industry Growth | 22.3% |
Revenue growth rate | 16.8% |
Return on equity | 14.4% |
Net Margin | 25.8% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses Breakdown
How Sinohealth Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 396 | 102 | 85 | 61 |
30 Sep 23 | 388 | 101 | 83 | 60 |
30 Jun 23 | 380 | 100 | 81 | 59 |
31 Mar 23 | 369 | 78 | 81 | 60 |
31 Dec 22 | 357 | 56 | 80 | 60 |
30 Sep 22 | 348 | 61 | 76 | 59 |
30 Jun 22 | 338 | 66 | 71 | 58 |
31 Mar 22 | 331 | 72 | 71 | 56 |
31 Dec 21 | 324 | 79 | 71 | 54 |
31 Dec 20 | 202 | 68 | 32 | 40 |
31 Dec 19 | 178 | 56 | 24 | 29 |
Quality Earnings: 2361 has high quality earnings.
Growing Profit Margin: 2361's current net profit margins (25.8%) are higher than last year (15.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2361's earnings have grown by 12.9% per year over the past 5 years.
Accelerating Growth: 2361's earnings growth over the past year (83%) exceeds its 5-year average (12.9% per year).
Earnings vs Industry: 2361 earnings growth over the past year (83%) exceeded the Healthcare Services industry 3.2%.
Return on Equity
High ROE: 2361's Return on Equity (14.4%) is considered low.